{
  "data": {
    "financials": {
      "sales_growth_3yr_avg": 7.9,
      "profit_growth_3yr_avg": 20.36,
      "roe_latest": 16.5,
      "roce_latest": 22.7,
      "pe_ratio": 22.2,
      "debt_to_equity": 0.02,
      "beta": 0.36
    },
    "dcf_inputs": {
      "free_cash_flow_latest_cr": 2818,
      "growth_rate_projection": 10,
      "shares_outstanding_cr": 80.74,
      "net_debt_cr": -7532,
      "tax_rate": 27.1
    },
    "qualitative": {
      "management_integrity_score": 9,
      "reasoning": "Cipla is renowned for its humanitarian approach ('Caring for Life') and strong corporate governance. The management has maintained a consistent track record of capital allocation and transparency. Despite typical sector regulatory hurdles (FDA observations), the company generally resolves them efficiently. High ESG scores and a debt-free status further reflect prudent management."
    }
  },
  "_cached_at": "2025-12-31T11:29:12.867780",
  "_symbol": "CIPLA"
}